Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 37, 2011 - Issue 1
Submit an article Journal homepage
351
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Low powder mass filling of dry powder inhalation formulations

Fadi Eskandar Novartis Pharma AG, PDU Inhalation, Basel, SwitzerlandCorrespondence[email protected]
,
Morgane Lejeune Novartis Pharma AG, PDU Inhalation, Basel, Switzerland
&
Stephen Edge Novartis Pharma AG, PDU Inhalation, Basel, Switzerland
Pages 24-32 | Received 04 Jan 2010, Accepted 26 Apr 2010, Published online: 12 Aug 2010

References

  • Byron B, Patton J. (1994). Drug delivery via the respiratory tract. J Aerosol Med, 7:49–75.
  • Barnes P, Grundstein M, Leff A, Woolcock A. (1997). Asthma. Philadelphia, PA: Lippincott-Raven.
  • Brown J, Zeman K, Benett W. (2001). Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis. J Aerosol Med, 14:443–54.
  • Stockley J, Rennad S, Rabe K, Celli B. (2007). Chronic obstructive pulmonary diseases. Oxford, UK: Blackwell.
  • Prime D, Atkins P, Slater A, Sumby B. (1997). Review of dry powder inhalers. Adv Drug Deliv Rev, 26:51–8.
  • Dolovich M, Ahrens R, Hess D, Anderson P, Dhand R, Rau J, . (2005). Device selection and outcomes of aerosol therapy: Evidences based guidelines. Chest, 127:335–71.
  • Newman S, Busse W. (2002). Evolution of dry powder inhaler design: Formulation and performance. Respir Med, 96:293–304.
  • Newman, S. (2004). Dry powder inhalers for optimal drug delivery. Expert Opin Biol Ther, 4:23–33.
  • Newman S, Peart J. (2009). Dry powder inhalers. In: Newman S, ed. Respiratory drug delivery essential theory and practice. Richmond, VA: Respiratory Drug Delivery, 257–307.
  • Daniher D, Zhu J. (2008). Dry powder platform for pulmonary drug delivery. Particuology, 6:225–38.
  • Lippmann M, Albert R. (1969). The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J, 30:257–75.
  • Lalor C, Hickey A. (1998). Pharmaceutical aerosols for delivery of drugs to the lung. In: Colbeck I, ed. Physical and chemical properties of aerosols. London: Blackie Academic and Professional, 391–428.
  • Telko M, Hickey AJ. (2005). Dry powder inhaler formulations. Respir Care, 50:1209–27.
  • Islam N, Gladki E. (2008). Dry powder inhalers (DPIs)—a review of device reliability and innovation. Int J Pharm, 360:1–11.
  • Jones M, Price R. (2006). The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharm Res, 23:1665–74.
  • European Pharmacopoiea. (2009). Bulk and tapped density of powders. 6th ed. 2.09.34. Strasbourg, France: Council of Europe. http://online.pheur.org [accessed May 6, 2010].
  • Carr RL. (1965). Evaluating the flow properties of solids‐classifying flow properties of solids. Chem Eng, 72:163–8.
  • United States Pharmacopoeia 32 National Formulary 27, 2nd supp. (2010). Powder flow <1174>. Rockville, MD: The United States Pharmacopoeial Convention, Inc. www.uspnf.com [accessed May 6, 2010].
  • Aakerberg V, Thalberg K. (2005). Dosing study with Omnidose powder dosing system. Proc. drug delivery to the lung 16, Edinburgh, UK, December 7–9.
  • Markefka P, Steckel H. (2002). Assessment of low levels of amorphous content in lactose by DVS and isothermal microcalorimetry. Arch Pharm Med Chem, 10:335.
  • European Pharmacopoiea. (2010). Preparations for inhalation: Aerodynamic assessment of fine particles. 6th ed., 7th supp., 2.9.18. Strasbourg, France: Council of Europe. http://online.pheur.org [accessed May 6, 2010].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.